Vertex Lunch and Learn-Exploring Sodium Channel Inhibition for the Management of Acute Pain

Thursday, July 9, 2026

12:15 PM - 1:45 PM PDT

Location: Level 6, Room 612

Industry Presenter(s)

BM

Brian Moran, MHA, BSN

I do not have any relevant financial / non-financial relationships with any proprietary interests.
IW

Ian Weber, MD

I do not have any relevant financial / non-financial relationships with any proprietary interests.
TM

Timothy Murphy, MD

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Please join us in this session for a comprehensive clinical overview of suzetrigine, a nonopioid pain signal inhibitor, in the management of moderate-to-severe acute pain, including postoperative pain. In this session we will explore the role of NaV1.8 in pain signaling, suzetrigine’s mechanism of action, and findings from our clinical studies evaluating suzetrigine. We will then gain clinical insights on the incorporation of its use in practice through discussions on real-world experience with suzetrigine.